Nova Scotia pledges help in opioid-abuse problemWorking group recommends raft of changes, including better training, information-sharing and disposal of drugs Nurses praise Insite clinic rulingNursing organizations says clinic saves lives, improves health. Ottawa to host conference on womens’ mental health The Royal Ottawa Mental Health Centre will hold one of Canada’s first conferences on women’s mental health. P.E.I. needs suicide prevention strategy: MSPEI society “Motherhood-type issues” were the focus at this year’s annual meeting of the Medical Society of Prince Edward Island according to Dr. Rachel Kassner, the society president. Pediatrician fights CPSO over uninsured services Oshawa doctor facing hearing over 'membership fee' maintains she did nothing wrong Risk of miscarriage rises with use of certain NSAIDs Quebec researchers’ suggestion of causal relationship draws criticism from head of Motherisk program Temporary ER staff make more medication errors Study suggests non-permanent workers in other departments may also need attention Trajenta: third DDP-4 inhibitor for type 2 diabetes Drug indicated for improving glycemic control in adults with type 2 diabetes. Clinical Notes: New Canadian guidelines for prostate cancer screening New Canadian evidence-based screening guidelines for prostate cancer promote early detection to reduce morbidity and mortality. Clinical Notes: New guidelines for fever in returning travellers Fever in a returning international traveller should initially be considered a medical emergency that requires prompt and thorough evaluation. Clinical Notes: Travel guidelines for older patients Older travellers should seek pre-travel advice early to allow for adequate pre-travel assessment and advice. Drug News: October 2011 Edurant: new NNRTI for HIV; Trajenta: third DDP-4 inhibitor for type 2 diabetes; Victrelis for chronic hepatitis C. First Previous 1704 1705 1706 1707 1708 Next Last
